It's unbelievable. IMO this is a fantastic buying opportunity. I view any possible further declines in the PPS as an absolute gift. NuPathe is here to stay! It's a tough pill to swallow for investors that purchased at higher prices but the smart one will simply load up on more shares at these bargain prices. Let the weak sell. GLTA
You are correct. RSI(14) is at 13.22, it is insane to see how oversold we are. I think the market is waiting for Armando to release news on commercialization and until then the share price will continue to bleed. The question is how much more?
My short term investment plan is to wait for the announcement and then analyze the terms and conditions. If they are good, then I will hold all the way to earnings, if not, then I may have to think for plan B. Quite honestly, I knew this was coming after Q2 CC, which is why I sold half of my position. I bought back in the last two trading days, thinking that it is now the bottom of the well, hope I made the right call.
It is very strange to see the market cap for PATH at 50M, with an FDA approved Zecuity that can potentially give revenue up to 100M per year. Something is not right, there is a disconnect. Either Armando / some pumpers here have done a terrific job brain washing people with all the hypes and potential of the product / $20-$30 buyout, Or we need to be more patient with the process and ride with the storm.
Agreed that Armando is doing everything according to what he initially planned (manufacturing plant, open label study, license agreement, projected Q4 launch), but he has failed to address the decline in share price. I like to give him the benefit of doubt. But again if one of the institutions is dumping millions of share, then one of the questions you have to ask to yourself is WHY? It is painful to digest, but if we were all to believe how good the product will be, then there would be no major selling. The price would have increased 5% every day not the other way around. Lets hope Armando is playing this well for his stockholders.